Hypertension affects 1 in 3 adults globally and is the leading modifiable risk factor for cardiovascular disease. Aldosterone ...

Sigvotatug Vedotin is an ADC that targets integrin αvβ6-positive tumor cells. It has an engineered antibody that ensures high ...

Altimmune shares cratered more than 50% on Thursday after its experimental obesity drug did not significantly improve liver ...

Insilico Medicine, a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter clinical ...

A new study details the development of a nanoparticle-based system that delivers concentrated chemotherapy specifically to ...

Too often as patients age, doctors pile on prescriptions. The practice, known as polypharmacy, can be dangerous at any age but is particularly hazardous for elderly people, from raising the risk of ...

Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

The FDA has accepted Aquestive Therapeutics’ new drug application for its Anaphylm sublingual epinephrine film for treating ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

In its order, CJ Upadhyaya-led bench directed PIL litigant to submit to CDSCO the scientific studies and data relied upon in ...